Is Procter & Gamble Stock Underperforming the Nasdaq?
While Procter & Gamble has notably underperformed the Nasdaq Composite recently, analysts remain moderately optimistic about the stock’s prospects.
Valued at a market cap of $343.4 billion, The Procter & Gamble Company (PG) is one of the world’s largest consumer goods companies, selling a broad portfolio of everyday household, personal care, health, beauty, and grooming products in about 180 countries and territories. The Cincinnati, Ohio-based company has built its business around globally recognized brands such as Tide, Pampers, Gillette, Head & Shoulders, Pantene, Olay, Oral-B, Always, Dawn, Bounty, and Crest.
Companies worth $200 billion or more are typically classified as “mega-cap stocks,” and PG fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the household & personal products industry. The company’s scale, powerful brands, extensive distribution network, and consistent product innovation give it a formidable position in the global fast-moving consumer goods industry.
Despite its notable strength, this personal care company has dipped 14.2% from its 52-week high of $167.25, reached on Feb. 27. Moreover, shares of PG have fallen 1.6% over the past three months, notably underperforming the Nasdaq Composite’s ($NASX) 2% fall during the same time frame.
In the longer term, PG has declined 7.8% over the past 52 weeks, lagging NASX’s 21.6% uptick over the same time period. Moreover, on a YTD basis, shares of PG are up marginally, compared to the index’s 13.6% rise.
To confirm its bearish trend, PG has been trading below its 200-day moving average since mid-March. However, it has recently started trading above its 50-day moving average since late May.
On Aug. 4, PG shares jumped 2.1% after the company announced a definitive agreement to acquire Thorne, a science-backed health and wellness company, from L Catterton’s Flagship Fund. The acquisition marks an important expansion of P&G’s Personal Health Care business, strengthening its foothold in the fast-growing premium wellness and personalized health markets.
In the competitive arena of household & personal products, Colgate-Palmolive Company (CL) has taken the lead over PG, with its shares rising 8.9% over the past 52 weeks and growing 15% on a YTD basis.
Despite PG’s recent underperformance, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of "Moderate Buy” from the 26 analysts covering it, and the mean price target of $160.58 suggests a 11.7% premium to its current price levels.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.